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ABSTRACT
limma is an R/Bioconductor software package that
provides an integrated solution for analysing data
from gene expression experiments. It contains rich
features for handling complex experimental designs
and for information borrowing to overcome the prob-
lem of small sample sizes. Over the past decade,
limma has been a popular choice for gene discov-
ery through differential expression analyses of mi-
croarray and high-throughput PCR data. The package
contains particularly strong facilities for reading, nor-
malizing and exploring such data. Recently, the ca-
pabilities of limma have been significantly expanded
in two important directions. First, the package can
now perform both differential expression and differ-
ential splicing analyses of RNA sequencing (RNA-
seq) data. All the downstream analysis tools previ-
ously restricted to microarray data are now available
for RNA-seq as well. These capabilities allow users to
analyse both RNA-seq and microarray data with very
similar pipelines. Second, the package is now able
to go past the traditional gene-wise expression anal-
yses in a variety of ways, analysing expression pro-
files in terms of co-regulated sets of genes or in terms
of higher-order expression signatures. This provides
enhanced possibilities for biological interpretation of
gene expression differences. This article reviews the
philosophy and design of the limma package, sum-
marizing both new and historical features, with an
emphasis on recent enhancements and features that
have not been previously described.
INTRODUCTION
Gene expression technologies are used frequently in molec-
ular biology research to gain a snapshot of transcriptional
activity in different tissues or populations of cells. These
profiles are then compared to identify gene expression
changes associated with a treatment condition or pheno-
type of interest. Gene expression studies may be random-
ized designed experiments in which a biological system is
perturbed, for example by a gene knock-out or by applying
a specified stressor. Such experiments are amongst the most
powerful tools in functional genomics, providing insights
into normal cellular processes as well as disease pathogen-
esis. Or they may be observational studies in which differ-
ent phenotypes are compared, diseased and normal tissue
for example or cells from different populations. Such stud-
ies are common in cancer research and in the study of cell
development. In either case, the study design can range from
simple two group comparisons to complex set-ups with sev-
eral experimental factors varying over multiple levels. Re-
searchers might be interested for example in whether a par-
ticular gene facilitates or blocks the action of a particu-
lar drug, in which case knock-down and wild-type sam-
ples both with and without drug treatment would be pro-
filed. Observational studies may involve multiple batch ef-
fects and covariates that must be accounted for in the anal-
ysis.
Despite the complexity, gene expression studies often in-
volve only a small number of biological replicates. The small
but complex nature of gene expression studies poses chal-
lenging statistical problems andmotivates the use of a num-
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ber of specialized statistical techniques in order to get the
most out of each data set. We have developed the limma
software over the past decade to provide a framework for
analysing gene expression experiments from beginning to
end in a flexible and statistically rigorous way.
The limma package is a core component of Bioconductor,
an R-based open-source software development project in
statistical genomics (1,2). It has proven a popular choice for
the analysis of data from experiments involvingmicroarrays
(3,4), high-throughput polymerase chain reaction (PCR)
(5), protein arrays (6) and other platforms. The package is
designed in such a way that, after initial pre-processing and
normalization, the same analysis pipeline is used for data
from all technologies.
Recently, the capabilities of limma have expanded sig-
nificantly in two important directions. First, the package
can now perform both differential expression (DE) and dif-
ferential splicing analyses of RNA sequencing (RNA-seq)
data (7,8). All the downstream analysis tools previously re-
stricted to microarray data are now available for RNA-seq
as well. These capabilities allow users to analyse bothRNA-
seq andmicroarray data with very similar pipelines. Second,
the package is now able to go past the traditional gene-wise
expression analyses in a variety of ways, analysing expres-
sion profiles in terms of co-regulated sets of genes or in
terms of higher-order expression signatures (7). This pro-
vides enhanced possibilities for biological interpretation of
gene expression differences.
This article reviews the philosophy and design of the
limma package, summarizing both new and historical fea-
tures, with an emphasis on recent enhancements and fea-
tures that have not been previously described. The article
outlines limma’s functionality at each of the main steps in a
gene expression analysis, from data import, pre-processing,
quality assessment and normalization, through to linear
modelling, DE and gene signature analyses.
MATERIALS AND METHODS
Figure 3 shows example diagnostic plots. Panel (A) shows
RNA-seq data from Pickrell et al. (9) that has been anal-
ysed as described by Law et al. (10). Panels (B) and (C) dis-
play the two-colour microarray quality control data set pre-
sented by Ritchie et al. (11). Panel (B) displays background
corrected but non-normalized intensities from one typical
array. Panel (C) was generated from a subset of 30 of the
control arrays after print-tip loess normalization (12).
Figure 4 shows example DE summary plots. Panels (A)
and (B) were generated using the two-colour microarray
data from GEO series GSE2593. Intensities were back-
ground corrected and normalized as previously described
(13). Panel (A) shows a volcano plot for the comparison of
samples with RUNX1 over-expressed versus wild-type sam-
ples, while panel (B) shows a Venn diagram of differentially
expressed probes for each of the three over-expressed genes
versus wild-type. Probes with false discovery rate less than
0.05 were considered to be differentially expressed. Panel
(C) uses RNA-seq data from GEO series GSE52870. The
data were analysed as described in Figure 5 of Liu et al. (7).
RESULTS
Statistical principles
limma integrates a number of statistical principles in a way
that is effective for large-scale expression studies. It operates
on a matrix of expression values, where each row represents
a gene, or some other genomic feature relevant to the cur-
rent study, and each column corresponds to an RNA sam-
ple. On the one hand, it fits a linear model to each row of
data and takes advantage of the flexibility of such models
in various ways, for example to handle complex experimen-
tal designs and to test very flexible hypotheses. On the other
hand, it leverages the highly parallel nature of genomic data
to borrow strength between the gene-wise models, allow-
ing for different levels of variability between genes and be-
tween samples, and making statistical conclusions more re-
liable when the number of samples is small. All the features
of the statistical models can be accessed not just for gene-
wise expression analyses but also for higher level analyses
of gene expression signatures. Figure 1 depicts the linear
model and highlights the statistical principles employed in
a typical limma analysis.
Linear models analyse complete experiments together. The
hallmark of the limma approach is the use of linear mod-
els to analyse entire experiments as an integrated whole
rather than making piece-meal comparisons between pairs
of treatments. This has the effect of sharing information be-
tween samples. Analysing the data as a whole also allows us
to model correlations that may exist between samples due
to repeated measures or other causes. This kind of analysis
would not be feasible were the data partitioned into subsets
and analysed as a series of pairwise comparisons.
Linear models permit very general analyses. Researchers
can adjust for the effects of multiple experimental factors or
can adjust for batch effects. The linear model might include
time course effects or regression splines. The linear model
could even include the expression values themselves of one
or more genes as covariates, allowing researchers to test for
inter-gene dependencies. Linearmodels allow researchers to
test very flexible hypotheses, not just simple comparisons
between groups but also interaction effects ormore complex
customized comparisons.
Shared global parameters link gene-wise models. A sepa-
rate model is fitted for each gene, but the gene-wise mod-
els can be linked by global parameters or global hyper-
parameters. The use of global parameters is a simple means
of sharing information between genes that can be used even
for the smallest experiments, because the global parameters
can be estimated from the entire data set involving all the
genes at once. This strategy allows the gene-wise models to
incorporate such things as correlations between duplicate
probes for the same gene, or correlations between related
RNA samples, or variations in quality between the RNA
samples.
Empirical Bayes borrows information between genes. The
highly parallel nature of gene expression experiments lends
itself to a particular class of statistical methods, called para-
metric empirical Bayes, that borrow information between
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Figure 1. Schematic of the major components that are central to any limma analysis. For each gene g, we have a vector of gene expression values (yg) and a
design matrix X that relates these values to some coefficients of interest (g). The limma package includes statistical methods that (i) facilitate information
borrowing using empirical Bayes methods to obtain posterior variance estimators (s2∗g ), (ii) incorporate observation weights (wgj where j refers to sample)
to allow for variations in data quality, (iii) allow variance modelling to accommodate technical or biological heterogeneity that may be present and (iv)
pre-processing methods such as variance stabilization to reduce noise. These methods all help improve inference at both the gene and gene set level in small
experiments.
genes in a dynamic way (14,15). The fact that the same lin-
ear model is fitted to each gene allows us to borrow strength
between genes in order to moderate the residual variances
(16). The estimated variance for each gene then becomes
a compromise between the gene-wise estimator, obtained
from the data for that gene alone, and the global variabil-
ity across all genes, estimated by pooling the ensemble of
all genes. This has the effect of increasing the effective de-
grees of freedom with which the gene-wise variances are es-
timated. It was an innovation of the limma package to show
that exact small-sample inference could be conducted us-
ing the empirical Bayes posterior variance estimators (16).
This approach has proven particularly advantageous in ex-
periments with small sample sizes, ensuring that inference
is reliable and stable even when the number of replicates is
small.
In recent years, the empirical Bayes procedures of limma
have been enhanced in two important ways. First, the global
variance estimate can now incorporate a mean-variance
trend (10,17,18). This is important because many gene ex-
pression technologies produce data that are less reliable at
lower intensities or abundances. Second, the relative weight-
ing of the gene-wise and global variance estimators no
longer needs to be the same for all genes. This allows a
sophisticated robust empirical Bayes procedure in which
hyper-variable genes are identified and treated separately
(18,19). Both of these enhancements improve statistical
power and accuracy by improving the modelling of the
global characteristics of the data in a more flexible way.
Quantitative weights allow for unequal quality. Another
unique feature of limma is the ability to incorporate quan-
titative weights into all levels of the statistical analysis,
from normalization to linearmodelling and gene set testing.
Weights can be applied to genes or toRNA samples or to in-
dividual expression values.Weights can be used to givemore
emphasis to control probes during normalization, or can be
used to down-weight measurements or samples that are less
reliable in a gene expression analysis. The weights can be
preset based on external quality information, or may be es-
timated from the expression data itself. The use of weights
increases power to detect differentially expressed genes, and
having a model based approach avoids the need for ad hoc
decisions about which observations or samples to filter out
(11).
RNA-seq and sequence data. All the downstream analysis
features of limma are available for RNA-seq and other se-
quence count data, as well as for data frommicroarrays and
other platforms. Traditionally, RNA-seq data require spe-
cialized software based on the negative binomial or similar
distributions (20). limma however is able to analyse RNA-
seq read counts with high precision by converting counts to
the log-scale and estimating the mean-variance relationship
empirically (Figure 3A). The mean-variance trend is con-
verted by the voom function into precision weights, which
are incorporated into the analysis of log-transformedRNA-
seq counts using the same linear modelling commands as
for microarrays. The resulting pipeline gives comparable
performance to the best of the negative binomial-based soft-
ware packages but with greater speed and reliability for
large data sets (10,21). Additionally, and conveniently, only
minimal pipeline changes are required when switching be-
tween analyses for RNA-seq and microarray experiments
within limma. This also means that the same statistical tests
with the same format of results and graphical displays are
available for both data types.
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Figure 2. The limmaworkflow. The diagram shows themain steps in a gene
expression analysis, alongwith individual functions thatmight be used and
the corresponding classes used to store data or results. Online documen-
tation pages are available both for each individual function and for each
major step.
Variance models allow for unequal variability. Expression
values often show some degree of heteroscedasticity, either
because there is a relationship between abundance andmea-
surement precision, or because some treatment conditions
are more heterogeneous than others. For example, tumours
might be more variable than normal tissue. Concern for
such effects has prompted some researchers to filter out low
intensity observations or to use Welch’s t-test for DE be-
tween two groups instead of classical pooled t-tests. The use
of weights and the ability to model global parameters al-
low limma to incorporate unequal variances in a number
of ways. One way is through estimating a mean-variance
trend, which can either be incorporated into the empirical
Bayes procedure as mentioned above or used to generate
observation weights (10). A recent development is the abil-
ity to estimate precision weights associated with treatment
groups or more generally with any given set of covariates.
More generally again, the mean-variance trend can be esti-
mated in a treatment-specific way, combining the two types
of heteroscedasticity mentioned above. These approaches
allow limma to model unequal variances even for experi-
ments with a small number of RNA samples. Importantly,
they accommodate unequal variances without compromis-
ing the linear modelling and empirical Bayes framework of
the package.
Using sets of genes to represent higher-level expression sig-
natures. In recent years, the linear modelling capabilities
of limma have been extended to higher-level expression sig-
nature analyses involving co-regulated sets of genes. The
idea is to use a set of genes, together with their log-fold-
changes, to represent the transcriptional signature of a bio-
logical process or cell type. One way that this is done is by
rotation technology, which permits statistical significance to
be tested for sets of genes for any linear model contrast (55).
A particular feature of rotation tests is the ability to incor-
porate prior information about the direction and strength
with which each gene is expected to contribute to the sta-
tistical signature. In this way, limma provides a uniquely
flexible means to relate new expression data sets to previ-
ous results collated from earlier experiments, taking into ac-
count for example the fold-change and direction of change
for each gene in the earlier experiment.
A closely related statistical approach implemented in
limma is to fit global covariance models, either to estimate
correlations between genes or to estimate the relatedness
between the DE profiles resulting from difference compar-
isons. These new analyses are described briefly later in this
article.
Pre-processing methods preserve information. Microarray
expression data are measured as intensities, which need to
be background corrected and normalized before any sta-
tistical analysis can be conducted. limma includes a range
of background correction and normalization procedures
suitable for different types of DNA microarrays or pro-
tein arrays. Notable are the maximum likelihood imple-
mentation of the normal-exponential convolution model
for background correction (22) and the implementation of
loess curves and normalization using quantitative weights.
The guiding principle in the pre-processing steps is to pre-
serve information, avoiding missing values or inflated vari-
ances (23). Normalized intensities are offset from zero be-
fore transforming to the log-scale to avoid missing values
or large variances. Offsets in a range of moderate values
have been shown to achieve an effective compromise be-
tween noise and bias (24).
Mean-difference plots. Measuring expression in multiple
RNA samples produces columns of correlated expression
values, which are highly correlated because they are mea-
sured on the same set of genes or genomic features. It has
long been established in the biomedical literature that the
level of agreement between correlated variables can be use-
fully examined by plotting differences versus means. Such a
plot is called a Bland–Altman plot (25) or a Tukey mean-
difference plot (26). Indeed the concept ofDE can be viewed
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Figure 3. Example diagnostic plots produced by limma. (A) Plot of variability versus count size for RNA-seq data, generated by voom with plot=TRUE.
This plot shows that technical variability decreases with count size. Total variability asymptotes to biological variability as count sizes increases. (B) Mean-
difference plot produced by the plotMA function for a two-colourmicroarray. The plot highlights negative (NC), constant (DR) and differentially expressed
(D03,D10,U03,U10) spike-in controls. Regular probes are non-highlighted. (C)Multidimensional scaling (MDS) plot of a set of 30microarrays, generated
by plotMDS. All arrays are biologically identical and the plot reveals strong batch effects. Distances represent leading log2-fold changes between samples.
as a measure of disagreement between expression measures
for the same genes in different samples. Mean-difference
plots were introduced to the two-colour microarray litera-
ture byDudoit et al. (27) and to the single-channel literature
by Bolstad et al. (28), who called them MA-plots. limma
generalized the concept of an MA-plot in two ways. First,
the idea was extended to apply to sets of single-channel ex-
pression values. In this case, the plot is used to compare each
sample to the average of all other samples. A virtual array
is constructed by averaging the log-expression value for all
the samples other than the sample of interest, and then a
mean-difference plot is made between the single array and
the virtual array. Second, the idea was extended to apply
to the fitted model objects. In this case, the plot compares
the log-fold-changes for a chosen contrast versus the aver-
age log-expression values of each gene across all samples. In
effect, this plots a coefficient of the linear model versus an
overall mean intercept parameter. These ideas were part of
the original limma package submitted to Bioconductor in
2003.
Parametric modelling versus permutation methods. It is
worth mentioning what limma does not do, which is permu-
tation or re-sampling-based inference. Permutation is fre-
quently useful in large-scale studies when the aim is to com-
pare two groups. However permutation has a number of dis-
advantages that make it unattractive for assessing DE in ex-
periments with complex designs. If permutation is applied
only to samples involved in two treatment conditions to be
compared, then the typically small number of replicates is a
severe limitation that will result in low power to detect dif-
ferences. If permutation is applied to all the samples in a
multi-factor experiment, then the composite null hypothe-
sis being testing is an uninteresting one and the power to
reject it may be highly dependent on the existence of DE
between treatment conditions that are not of primary in-
terest. In other words, permutation cannot be tuned to test
specific null hypotheses of interest in a designed experiment.
Even more importantly, permutation assumes that all sam-
ples are independent and identically distributed under the
null hypothesis, and these assumptions are frequently, usu-
ally perhaps, unrealistic. In addition, permutation is poten-
tially misleading when the samples are correlated or of un-
equal precision. In otherwords, permutation is unable to ac-
commodate blocking structures or quality weights. In small,
complex experiments, the potential compromises involved
in modelling expression values using parametric distribu-
tions, which can never be perfectly correct, are outweighed
by the gains in precision and accuracy bymodelling the vari-
ance structure more realistically.
Pre-processing RNA-seq and other sequencing data
Figure 2 provides an overview of the functions available at
each stage of a gene expression analysis. The first step is to
import expression data into the R session.
limma accepts RNA-seq data in the form of a matrix of
read counts, with rows for genomic features and columns
for RNA samples. Alternatively it can accept a DGEList
object from the edgeR package. The genomic regions are
often genes or exons, but could in principle be any genomic
feature of interest. In this article, the regions will usually be
called genes for simplicity of terminology. The read counts
are processed by the voom function in limma to convert
them into log2 counts per million (logCPM) with associ-
ated precision weights. The logCPM values can be normal-
ized between samples by the voom function or can be pre-
normalized by adding normalization factors within edgeR.
Raw read counts are assembled outside limma using tools
such as featureCounts (29), HTSeq-counts (30) or RSEM
(31). The authors of this article find the Subread (32) and
featureCounts pipeline particularly convenient because it is
fast, accurate (8) and can be run from the R prompt using
the Rsubread package. The data input to limma should be
counts, rather than popular expression summaries such as
reads-per-kilobase-per-million (RPKM), so that limma can
estimate the appropriate mean-variance relationship. The
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Table 1. Standard microarray data formats handled by limma
Software Vendor Channels
Agilent Feature
Extraction
Agilent
Technologies
1/2
ArrayVision GE Healthcare 1/2
BlueFuse BlueGnome 1/2
GenePix Molecular Devices 1/2
BeadScan/GenomeStudio
Illumina Inc. 1
ImaGene BioDiscovery 1/2
QuantArray PerkinElmer Life
Sciences
1/2
ScanArray Express PerkinElmer Life
Sciences
1/2
SMD Stanford 1/2
Spot CSIRO 1/2
Data output by the above software can be read-in using read.maimages
or read.ilmn. limma can read files in other formats, provided the user pro-
vides the names of the columns containing foreground and background
intensities.
voom output can be converted to RPKM values for con-
venience of interpretation, by subtracting log-gene-lengths,
but this should be done after running voom rather than be-
fore.
After running voom, downstream analysis for RNA-
seq data is the same as for any other technology. For ex-
ample, RNA-seq data can be explored using boxplots or
mean-difference plots, similarly to single-channel microar-
ray data. More detail about this is given in the following
sections.
Preprocessing microarray data
Reading or importing data. For DNA or protein microar-
rays, importing expression data often involves reading out-
put files created by an image analysis program. Alterna-
tively, a data frame of expression values may be read from
a file or data might be directly imported as an R object.
The main limma function to read image output files
is read.maimages. This function directly supports formats
written by many different image analysis programs in-
cluding GenePix, Agilent Feature Extraction, ArrayVision,
BlueFuse, ImaGene, QuantArray and SPOT (Table 1). It
also supports the Stanford Microarray Database format.
Output in other formats can be read if the appropriate col-
umn names are supplied. Two-colour and single-channel
data are both supported. Illumina BeadChips need special
treatment: output from Illumina’s GenomeStudio can be
read by read.ilmn if exported as a text file or by read.idat
if in binary format.
Probe annotation is read automatically if contained in the
image output files, or can be read separately and added to
the data object. readGAL supports the GenePix Gene Ar-
ray List format. read.maimages includes the ability to gen-
erate spot quality weights according to any user-specified
rule based on any information found in the image output
files.
limma includes many possibilities for using or high-
lighting different types of control probes. The functions
readSpotTypes and controlStatus are provided to conve-
niently classify probes based on text found in the input files.
The status of each probe is automatically carried through
to appropriate downstream functions.
The function readTargets is provided to read information
about the RNA samples or targets. This information typi-
cally includes information about the treatment conditions
and experimental design.
limma can accept data objects containing expression data
from other Bioconductor packages. It can accept mar-
rayNorm objects from themarray package, PLMset objects
from the affyPLM package, vsn objects from the vsn pack-
age or objects of any class inheriting from ExpressionSet.
Alternatively, expression data can be supplied as a numeric
matrix. Expression values can be image intensities or nor-
malized log-expression values.
Background correction. When array images are read, it
is usual to read both foreground and background inten-
sities for each probe. The background intensities can be
used to derive an estimate of the ambient intensity affect-
ing each probe. Removing this non-specific signal from the
foreground intensity of each probe is called background
correction and it is typically the first step in processing
microarray images. Simply subtracting background from
foreground intensities is too heavy-handed (23). The limma
backgroundCorrect function offers a range of more sophis-
ticated alternatives, most unique to the package. These in-
clude a method based on a convolution of normal distribu-
tions (33) and a normal-exponential (normexp) convolution
(23) with different options for parameter estimation (22).
The plotFB function plots foreground against background
intensities for each array and is useful for choosing an ap-
propriate correction method.
Illumina arrays again benefit from special treatment. The
nec function implements normexp background correction
for Illumina BeadChips making special use of the control
probes that are specific to these arrays (24).
The propexpr function compares intensities to those of
negative control probes to estimate the total proportion of
probes on each array that correspond to expressed genes
(34). This provides an estimate of the size of the transcrip-
tome in each sample and is useful for deciding how many
probes to filter from downstream analyses.
Normalization. Before meaningful comparisons can be
made between treatment conditions in a designed experi-
ment, it is critical that the expression values are normal-
ized so that all the samples are as far as possible on the
same measurement scale. The purpose of normalization is
to remove systematic effects due to technical differences
between the assays unassociated with the biological dif-
ferences of interest. Different technology platforms intro-
duce different biases and so require different normaliza-
tion methods. The normalizeWithinArrays function nor-
malizes data from two-colour microarrays by aligning the
two channels for each array. A popular method is to re-
move intensity-dependent dye-biases and spatial artefacts
from M-values (log-intensity ratios) using locally weighted
regression (loess) (35). The normalizeBetweenArrays func-
tion aligns expression values between samples for one-
colour microarrays and other single channel platforms us-
ing methods such as quantile normalization or cyclic loess
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(28). Both functions provide a range of different normal-
ization methods suitable for different platforms. normal-
izeBetweenArrays also implements separate channel nor-
malization methods for two-colour arrays (36,37). limma is
the only software to allow the use of quantitative weights
in loess normalization (38), giving it the ability to down-
weigh less reliable probes or to give higher priority to con-
trol probes or house-keeping genes. The latter ability has
been exploited for normalizing assays when the proportion
of differentially expressed genes may be high, for example
boutique arrays (39), miRNA arrays (40), PCR arrays, pro-
tein arrays or protein mass spectrometry. Other enhance-
ments include the ability to replace the loess curve with a
spline curve that has high robustness breakdown proper-
ties, and the ability to apply empirical Bayes moderation to
the spline curves for multiple regions within the same array
(robust-spline normalization).
The neqc function implements quantile normalization
for Illumina BeadChips making special use of the control
probes specific to these arrays (24).
All the between-arrays normalization methods are acces-
sible for RNA-seq data from within the voom function.
Alternatively, voom has the ability to respect normaliza-
tion factors computed outside of limma by methods such
as trimmed mean of M-values (41) or conditional quantile
normalization (42).
Graphical exploration of data quality
Diagnostic plots allow the user to visually inspect data from
a designed experiment in order to identify potential quality
problems, such as degraded samples, or problems that arise
due to array handling or sample processing. Such displays
may also reveal systematic biases that should be removed
prior to downstream analysis. Figure 3 presents examples
from three different plotting functions.
Plots for individual arrays include the foreground–
background plots mentioned above (plotFG), image plots
that can reveal inconsistencies across the array surface (
imageplot) and mean-difference plots that show
intensity-dependent trends in the log-ratios of two-
colour arrays (plotMA, Figure 3B). The plotMA function
can show similar plots for single channel data. In this case,
the mean-difference plot is constructed by comparing the
log-expression values for that sample compared with the
mean of all other samples. The plotMA function makes it
simple to highlight particular subsets of probes or genes, for
example control probes. Control probes are automatically
highlighted if they have previously been identified using
controlStatus (Figure 3B).
The distribution of expression values can be compared
between samples using box plots or density plots (plotDen-
sities). The latter is particularly useful when considering
separate channel analyses of two-colour arrays.
Finding differentially expressed genes
Exploration of sample relationships. After the pre-
processing steps described above, the next major analysis
stage is to identify differentially expressed genes. It is advis-
able to begin the DE analysis with a plot that visualizes the
relative differences in transcriptional profile between the
samples. The plotMDS function uses multi-dimensional
scaling to plot differences in expression profiles between
different samples (Figure 3C). Distances between samples
on the plot represent ‘leading fold change’, which is defined
as the root-mean-square average of the log-fold-changes
for the genes best distinguishing each pair of samples.
This provides a type of unsupervised clustering of the
samples. It is useful for examining how different are the
profiles produced by different experimental factors and for
identifying unexpected patterns, such as batch effects, that
should be adjusted for during the linear model analysis.
This helps guide the construction of the design matrix used
for the linear modelling below.
The plotRLDF function provides a supervised plot of the
samples that shows whether the expression data can distin-
guish a set of known groups. The function implements a
regularized version of linear discriminant functions.
The removeBatchEffect function can be used to remove
systematic variation due to batches or other covariates prior
to plotting the data so that the effect of treatments can be
better seen.
Linear modelling. The core component of the limma pack-
age is the ability to fit gene-wise linear models to gene ex-
pression data in order to assess DE (16). The basic idea is to
estimate log-ratios (for two-channel data) or log-intensities
(for single-channel data) between two or more target RNA
samples simultaneously.
Each analysis begins with a matrix of expression levels,
with probes/genes/exons in the rows and different sam-
ples (biological/technical replicates) in the columns. The
linear modelling is performed in a row-wise fashion, with
regression coefficients and standard errors either directly
estimating the comparisons of interest or via contrasts.
Test-statistics are obtained for gene ranking that can be
further summarized at the gene set level to perform gene
signature/pathway-level ranking.
The flexibility of the linear modelling approach allows al-
most any experimental design to be handled. Experiments
with two or more groups, factorial and time-course designs,
and internal controls such as dye-swaps can all be modelled
and summarized using the lmFit function.Where appropri-
ate, nuisance variables such as batch and dye effects can also
be modelled. Models can be fit robustly or by least squares.
Once a linear model is fitted, the makeContrasts function
can be used to form a contrast matrix. The fitted model ob-
ject and contrast matrix are used by contrasts.fit to compute
log2-fold-changes and t-statistics for the contrasts of inter-
est. This allows all possible pairwise comparisons between
treatments to be made.
The plotSA function provides a useful diagnostic plot of
the linearmodel fit, plotting gene-wise residual standard de-
viations against average log-expression. This allows mean-
variance trends to be readily identified, should they exist.
Quality weights and heteroscedasticity. limma is the only
package that allows variations in quality to be handled in a
graduated way via quantitative weights. Both observation-
level (2,10,43) and sample-specific weights (11) can be used
in an analysis. For microarray data, the arrayWeights func-
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tion estimates relative array variances, which are converted
to weights that can be used in the linear model analysis to
down-weight observations from less reliable arrays. Probe
and array weights can be easily combined by multiplying
them together and, when used appropriately, have been
demonstrated to increase power to detect DE (11,43).
For RNA-seq data, the voomWithQualityWeights
function combines observation-level and sample-specific
weights for use in the subsequent linear modelling.
Blocking and random effects. limma includes a unique
strategy for incorporating the fact that observations or sam-
ples may be correlated. The strategy is similar to fitting a
random effects model, with the difference that all genes are
constrained to share the same intrablock correlation. The
duplicateCorrelation function is used to estimate the con-
sensus correlation. The correlation structure is then incor-
porated into the linear model fit and hence into all tests for
DE. Originally the idea was used to estimate the correlation
between replicate copies of the same probe on a microarray
(44). The correlation strategy preserves more information
than simply averaging the replicate probe copies. More gen-
erally, the same idea is also used to model the correlation
between related RNA samples, for example repeated mea-
sures on the same individual or RNA samples collected at
the same time.
Separate channel analysis of two-colour microarrays. Two-
colour microarrays are traditionally analysed in terms of
log-ratios between the two channels hybridized to each
probe. limma also provides the possibility of analysing two-
colour microarrays as if they were single channel microar-
rays with two separate samples hybridized to each physi-
cal array. This provides a very powerful type of analysis
in which intensities can be directly compared between mi-
croarrays. The pairing of the red and green channels from
each array is kept track of by estimating the correlation be-
tween the two channels hybridized to each probe (37). This
type of separate channel analysis uses the intraspotCorrela-
tion and lmscFit functions.
All the linear model fits, whether using lmFit or lmsc-
Fit, produce a fitted model object with the same structure.
The same fitted model applies regardless of whether corre-
lations have been estimated, whether robust regression or
least squares has been used, or whether quality weights have
been included. This consistency allows the same framework
for DE to be used for all experimental designs and platform
technologies.
Testing for DE. An empirical Bayes framework to borrow
information between genes when estimating the variances is
implemented in the eBayes function. Gene-wise variances
are squeezed towards the common or trended variance,
which reduces the number of false positives for genes with
very small variances and improves power to detect DE for
genes with larger variances. limma includes a robustified
shrinkage strategy that allows for gene-wise shrinkage fac-
tors to be estimated (18). This ensures unusually large vari-
ances are not squeezed too heavily, reducing the chance that
they will appear statistically significant, while more consis-
tently expressed genes are squeezed more severely towards
the common variance. This robust strategy offers the bene-
fits of shrinkage to themajority of the genes, whilst negating
the effects of outliers.
For each coefficient in the linear model or contrast, em-
pirical Bayes moderated t-statistics and their associated P-
values are generally used to assess the significance of the
observed expression changes. T-statistics can also be trans-
lated into Bayesian log-odds of DE. Moderated F-statistics
that combine the t-statistics for all contrasts into an overall
test of significance for each gene can also be used.
When one has a particular cut-off for log-fold-change in
mind, the treat function can be used to test whether the log2-
fold-change is greater than a threshold rather than merely
different to zero (45). This can be effective for prioritizing
results that are biologically aswell as statistically significant.
limma provides a number of options to adjust tests for
multiple testing. Users can control either the family-wise
type I error rate or the false discovery rate (46). As well as
the usual control for multiple testing across multiple genes,
limma is the only software package to provide methods for
error rate control across multiple contrasts and genes simul-
taneously. For individual tests, multiple testing can be ap-
plied using the topTable function. The decideTests function
gives access to the full range of options.
To visualize the results of a DE analysis for single or mul-
tiple contrasts, limma provides a number of plotting op-
tions. Figure 4 shows three such displays: a volcano plot
showing the DE results from a single condition, a Venn dia-
gram showing the number of differentially expressed genes
in multiple experimental conditions and a barcode enrich-
ment plot highlighting a particular gene signature in a DE
analysis ranked by moderated t-statistics.
Another useful plot is produced by plotMA, which plots
estimated log-fold-changes against mean log-expression for
each gene. This allows the magnitude of changes to be vi-
sualized in the context of overall expression level; see for
example Figure 5C of Liu et al. (7).
Testing for differential splicing. The linear model frame-
work of limma is extended to test very easily for differential
splicing events when exon-level expression data are avail-
able. The data can be either from an exon microarray or
from RNA-seq data summarized at the exon level. In ei-
ther case, the approach is based on fitting linear models
to the exon-level expression data. The approach can relate
differential exon usage to continuous as well as categori-
cal predictors or to any contrast in a linear model. The test
is conducted by the diffSplice function and results are dis-
played using plotSplice and topSplice. The plotExons func-
tion is also useful for exploring exon expression for individ-
ual genes. This approach is considerably faster than alterna-
tive approaches to differential splicing, making large-scale
surveys of differential exon usage feasible.
Higher-level analyses
Linear modelling of gene expression data provides the ideal
platform from which to attack larger functional genomic
questions related to gene-wise independence or interac-
tion and the decomposition of gene signatures into dis-
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Figure 4. Example plots displaying results fromDE and gene set analyses. (A) Volcano plot showing fold changes and posterior odds of DE for a particular
comparison (RUNX1 over-expression versus wild-type in this case), generated by volcanoplot. Probes with P < 0.00001 are highlighted in red. (B) Venn
diagram showing overlap in the number of DE genes for three comparisons from the same study as (A), generated by the vennDiagram function. (C) Gene
set enrichment plot produced by barcodeplot. The central bar orders differentially expressed genes by significance from up to down upon Pax5 restoration
in an RNA-seq experiment (7). The vertical bars mark genes that are induced (red) or repressed (blue) upon the transition from large cycling pre-B cells
to small resting pre-B cells during normal B cell development according to the published literature (47). The plot shows a strong positive concordance
between Pax5 restoration and the large to small cell transition. The roast function can be used to assign statistical significance to this correlation.
tinct molecular pathways. This section describes higher-
level analyses involving multiple genes.
Estimating the proportion of true null hypotheses. First we
considerDE froma genomic point of view. TheDEanalyses
described so far identify individual differentially expressed
genes according to an FDR criterion. However, for most
studies, there are likely to be false negatives: truly differen-
tially expressed genes that are not detected as differentially
expressed because the study did not have enough statistical
power to identify them with confidence.
The propTrueNull function estimates the number of truly
differentially expressed genes that remain to be identified.
Mathematically, it estimates the proportion of true null hy-
potheses in a collection of hypothesis tests given a vector of
P-values. In a gene expression study, it estimates the propor-
tion of non-differentially expressed genes, out of all tested,
for any contrast in the linear model. The function imple-
ments a number of differentmethods for estimating the pro-
portion of true nulls, ranging fromquick and simple tomore
computationally demanding. The default is based on aver-
aging local false discovery rates across the P-values (19).
Other methods are the histogram method of (48,49), the
convex decreasing density estimate of (50) and a very simple
estimate based on averaging the P-values.
Genuine association of gene expression profiles. Gene ex-
pression experiments typically involve a number of different
treatment conditions. A question that often arises is this:
to what extent do two different treatments produce simi-
lar or different expression profiles? One way to address this
question is to count the overlap in differentially expressed
genes from the two treatments, as in Figure 4B. This ap-
proach however is often too crude. It is very sensitive to the
significance cut-off used to identify differentially expressed
genes, has little chance of success in situations where power
to detect differentially expressed genes is relatively low and
is subject to technical biases when both treatments are com-
pared back to the same control samples. The genas function
(19) addresses these problems. It tests whether two different
contrasts in a linear model affect the same genes in sim-
ilar or different ways, adjusting for biases, without need-
ing to apply a significance cut-off for assessing DE. More
technically, it estimates the true biological correlation be-
tween the log2-fold-changes of two different contrasts. By
biological correlation, we mean the correlation that would
exist between log-fold-changes if they could be measured
perfectly without any statistical error. genas is based on a
bivariate generalization of the empirical Bayes model that
is used to assess DE in limma. This method is particularly
powerful for gaining insight into commonly affected gene
pathways when the changes are small but consistent. For in-
stance, applying genas to a microarray study looking at the
relationship between polycomb repressor complex (PRC) 1
and PRC2 facilitated the discovery of the opposing roles of
these two complexes (51). This relationshipwould have been
missed if the analysis had been restricted to the statistically
significant genes from each contrast alone.
Gene set testing. Gene set analyses assess the overall sig-
nificance of a set of co-regulated genes. Each gene set is
chosen to represent a particular molecular pathway or some
other biological process of interest. Gene sets are defined by
gene annotation external to the current expression study, for
example from Gene Ontology (GO) database (52) or from
previous expression studies. For gene sets defined by previ-
ous studies, the genes may optionally be annotated with the
direction and magnitude of expression changes in the ear-
lier experiment. In this way, a gene set may contain genes
both positively and negatively associated with the molecu-
lar pathway that it represents.
limma contains a range of options for gene set testing via
the goana, geneSetTest, camera, roast and romer functions.
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The goana function provides a traditional GO overlap anal-
ysis but with the added ability to adjust for gene length or
abundance biases in RNA-seq DE detection. goana uses
generalized hypergeometric tests to test for enrichment of
GO terms in the list of differentially expressed genes (53).
It operates directly on the fitted model object and extracts
differentially expressed genes automatically.
Unlike goana, the other gene set options do not require a
significance threshold to be applied to identify differentially
expressed genes. The simplest approach is implemented in
the geneSetTest and wilcoxGST functions, which perform
rank-based tests (13). These tests assess whether the speci-
fied set of genes is more highly ranked in an ordered list of
all genes thanwould be expected by chance. These tests have
been found to give an effective ranking of biologically sig-
nificant pathways (54), but they implicitly assume that the
expression level of each gene is conditionally independent
of other genes and hence give optimistic P-values (55).
More sophisticated competitive tests that take into ac-
count dependence between the genes in the linear modelling
framework are implemented in the camera function (56).
Camera computes a variance inflation factor from the inter-
gene correlation and uses this to adjust the variance of the
summary statistics. This avoids optimistic P-values in the
test results, but also reduces statistical power. Camera has
been used successfully in a number of biomedical projects
(57).
The roast and mroast functions implement a self-
contained test of whether any worthwhile subset of the
specified set of genes is differentially expressed (55). These
functions use rotation tests, a specialized simulation tech-
nique for multivariate normal models (58). Rotation can be
viewed as a smoothed version of permutation that is suitable
for linear models. Rotation occurs only in the residual space
of the linear model in such a way that any coefficients in the
linear model other than the contrast being tested are held
constant (55,58). Roast can provide good statistical power
in small complex gene expression experiments. Of all gene
set tests, roast has the unique ability to take into account di-
rectional annotation information about genes in the set. It is
able to accommodate genes both positively and negatively
associated with a specified pathway, as well as the magni-
tude of change of each gene. It is therefore especially useful
for finding similarities in gene expression patterns between
different expression studies (57,59–61) (Figure 4C). Other
potential applications for roast include those where the set
might not be made up of genes, for example exon-level ex-
pression analyses to test whether any exon of a given gene
is differentially expressed.
Gene set enrichment analysis (GSEA) is an approach
that correlates a large database of co-regulated gene sets
with respect to a microarray or RNA-seq data set (62,63).
GSEA is a hybrid approach: it is competitive in that dif-
ferent sets are pitted against one another, but significance
is evaluated by permutation of sample labels. The romer
function in limma implements a GSEA approach that is
based on rotation instead of permutation. Like camera and
mroast, it can be used with a battery of gene sets and with
any linear model. The limma authors maintain mouse and
human versions of the Molecular Signatures Database col-
lections (64) in R binary format that can be conveniently
used with camera, mroast or romer (http://bioinf.wehi.edu.
au/software/MSigDB).
The use of gene sets require that gene symbols and an-
notation be matched between different databases and stud-
ies. Gene symbols change over time, so limma includes
the alias2Symbol and alias2SymbolTable functions to map
gene symbol aliases to current official gene symbols. The
id2indices function matches gene identifiers in a collection
of gene sets to those in the expression matrix, in a format
suitable for input into camera, mroast or romer.
A gene set test can be visualized using the barcodeplot
function (Figure 4C). Genes are ranked according to their
DE results in the current study, then genes from the a pri-
ori set are highlighted by vertical bars, with a smoother line
showing the relative enrichment of the gene set amongst
high and low ranked genes. Barcodeplot is similar to the set
location plot introduced by Subramanian et al. (63), with a
number of enhancements, especially the ability to incorpo-
rate genes with positive and negative prior directions. Bar-
codeplot can optionally display varying weights for differ-
ent genes, for example log-fold-changes from a previous ex-
periment.
User-interface
Object-oriented programming. A simple but appropriate
object-oriented paradigm provides users with a consistent
analysis interface that is very easy from a user point of view.
Many limma functions are generic or operate appropriately
on objects of different classes. limma defines a number of
classes that have been tailored to handle both microarray
and RNA-seq data. The philosophy has been to define sim-
ple list-based data objects that can be easily explored and
manipulated by users, in the same style as familiar, long-
standing core functions in R such as lm and glm.
For raw intensity data, the classes ‘RGList’ and ‘ELis-
tRaw’ are used to store two-colour and single-channel data,
respectively. These objects are often created using the func-
tion read.maimages and contain the raw values from the im-
age analysis output files along with probe annotation infor-
mation.
Normalized data are stored in ‘MAList’ or ‘EList’ ob-
jects. Normalized two-colour data are converted from red
and green intensities, R and G, intoM and A-values, which
hold the log-ratio and average log-intensity values for each
spot. Single channel data are background corrected and
log2 transformed and stored in an ‘EList’ object. For RNA-
seq data, the voom transformedmatrix of gene/exon counts
is also stored in an ‘EList’ object.
The next major classes store output from a DE analysis.
‘MArrayLM’ objects store the result of fitting gene-wise lin-
ear models to the normalized intensities or log-ratios. Ob-
jects of this class are created by the lmFit and eBayes func-
tions. After running decideTests, an object of class ‘TestRe-
sults’ stores the results of testing a set of contrasts equal to
zero for each probe/gene.
All of these data classes obey many analogies with ma-
trices. In the case of ‘RGList’, ‘MAList’, ‘EListRaw’ and
‘EList’, rows correspond to probes/genes and columns to
different samples. In the case of ‘MarrayLM’ and ‘TestRe-
sults’ rows correspond to unique probes/genes and the
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columns to linear model coefficients or contrasts. The stan-
dard R functions summary, dim, length, ncol, nrow, dim-
names, rownames, colnames have methods for each of these
classes. Objects of any of these classes may also be subset-
ted. Multiple data objects may be combined by rows to add
extra probes, or by columns to add extra arrays.
Furthermore all of these classes may be coerced to be of
class matrix using as.matrix, although this entails loss of in-
formation. Fitted model objects of class ‘MArrayLM’ can
be coerced to class data.frame using as.data.frame inR. The
first five classes belong to the virtual class ‘LargeDataOb-
ject’ for which a showmethod is defined to display the lead-
ing rows of a large vector, matrix or data.frame.
Computational efficiency. The limma package is imple-
mented primarily in R (65) and includes some C code to
speed up computationally intensive steps. At every stage,
effort has been expended to achieve high numerical relia-
bility and efficiency. The memory requirements are linear
in the number of genes and the number of samples. Most
estimation procedures finish in a few seconds on a standard
desktop computer and virtually all in less than a minute.
Availability. The limma software is freely available on-
line as part of the Bioconductor project (http://www.
bioconductor.org). More than 120 other Bioconductor
packages make use of limma (as of March 2014). The
limma package is used as a building block or as the un-
derlying computational engine by a number of software
projects designed to provide user-interfaces for gene ex-
pression data analysis including limmaGUI (66), affylmGUI
(67), WebArray (68), RACE (69), CarmaWEB (70), Goul-
phar (71), MAGMA (72), Asterias (73), GenePattern (74),
GEO2R (http://www.ncbi.nlm.nih.gov/geo/geo2r), the EBI
expression atlas (75), Guide (76) and Degust (http://www.
vicbioinformatics.com/degust).
Documentation. The limma package provides three levels
of documentation. First, each function has its own docu-
mentation page that concisely but completely specifies the
input data, options and output format of the function. Sim-
ilarly, each data class has a documentation page explaining
all the required and optional components of objects of that
class. Care is taken to adhere to the same standards and style
that users will be familiar with from help pages in the base
R packages.
Second, a series of more general subject help pages serve
to link together functions and classes that are used for re-
lated purposes. The subject pages cover the topics of (i) in-
troduction, (ii) classes, (iii) reading data, (iv) background
correction, (v) normalization, (vi) linear models, (vii) indi-
vidual channel analysis of two-colour data, (viii) hypothesis
testing for linear models, (ix) diagnostics and quality assess-
ment, (x) gene set tests and (xi) RNA-seq.
Third, the package comes with an extensive user’s guide
of over 120 pages, available from the drop-down menu
in Windows or alternatively launched by the limmaUsers-
Guide command. The user’s guide gives detailed advice on
how to analyse a variety of common study designs. It also
includes 10 fully worked case studies for which full data and
code are provided.
Users who need more help or advice are invited to
post questions to the Bioconductor support site (https://
support.bioconductor.org). Questions are usually answered
promptly, either by the authors or by other members of
the Bioconductor community. The support site archives an-
swers to many common questions, including many queries
about experimental design and setting up appropriate de-
sign matrices.
DISCUSSION
This article has summarized the current features of the
widely used, open source limma package for gene expression
analysis. This software provides an integrated data analy-
sis solution, using advanced computational algorithms to
deliver reliable performance on large data sets and object-
oriented ideas to represent expression data and simplify the
user interface. New functionality is continually being added
as model refinements and new use cases arise.
Although originally developed with microarray data in
mind, the development of the voom methodology unlocks
the majority of analysis methods for use on RNA-seq data,
such as random effects modelling and gene set testing. As
with any data analysis problem, the appropriate combina-
tion ofmethods to use will depend upon the biological ques-
tion, platform used (microarray/RNA-seq) and experimen-
tal design.
Being R-based, reports of limma analyses can be com-
piled using Sweave (77) or knitr (78) and provided along
with the rawdata in a compendium to promote reproducible
research in genomics (79).
Applications of limma’s linear modelling strategy beyond
the intended analysis of gene expression data have been
made in a variety of applications, including the analysis of
data fromNuclearMagnetic Resonance spectroscopy, PCR
(includingNanostring), quantitative proteomics (80), DNA
methylation arrays and comparative ChIP-seq (81).
As the cost of collecting genome-wide profiles continues
to fall, we expect the popularity of this approach to con-
tinue to grow, with new applications in the analysis of single
cell gene expression data, CRISPR/Cas9 knock-out screens
and methylation analysis (82).
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